Modeled hepatic and plasma exposures of fluvastatin prescribed alone in subjects with cytochrome <em>P450 2C9*3</em> likely associated with reported adverse drug events

Koichiro Adachi

[29P-am283] Modeled hepatic and plasma exposures of fluvastatin prescribed alone in subjects with cytochrome P450 2C93* likely associated with reported adverse drug events

Koichiro Adachi¹, Katsuhiro Ohyama², Yoichi Tanaka³, Norie Murayama¹, Makiko Shimizu¹, Yoshiro Saito³, ○Hiroshi Yamazaki¹ (1. Showa Pharma Univ, 2. Tokyo Univ Pharm and Life Sci, 3. NIHS)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[29P-am] Pharmacology 1

[29P-am283] Modeled hepatic and plasma exposures of fluvastatin prescribed alone in subjects with cytochrome P450 2C93* likely associated with reported adverse drug events

Password

Presentation information

[29P-am] Pharmacology 1

[29P-am283] Modeled hepatic and plasma exposures of fluvastatin prescribed alone in subjects with cytochrome P450 2C9*3 likely associated with reported adverse drug events

Password

[29P-am283] Modeled hepatic and plasma exposures of fluvastatin prescribed alone in subjects with cytochrome P450 2C93* likely associated with reported adverse drug events